The IDS is a patented and Food and Drug Administration-approved computer decision support system with the potential to be used with any therapeutic agent. The IDS uses a unique mathematical model, originally developed to titrate doses of immunosuppressive agents, that examines the individual patient response to a previous change in drug dose and calculates a new dose based on the next desired target level of a marker. In brief, the IDS model comprises three basic equations. The first calculates the new dose of drug based on the previous dose–response history. The second is a stochastic loop equation that is linked to and modifies the result of the first equation to account for individual variations in response; the stochastic loop accounts for nonlinear affects. The third calculates the expected level of marker following the dose change. The ability to modify therapy based on individual response, and then provide the practitioner and patient with an estimate of the outcome in response to that change, is a unique feature of the IDS.
Dimensional Dosing Systems, Inc. holds domestic and international patents for the Intelligent Dosing System (IDStm), a computerized decision support system approved by the FDA as a Class II Medical Device. Dimensional Dosing Systems offers innovative computer-assisted dosing technology that enables people to receive a safer, more effective, and more cost effective course of medications. Our proprietary dose-response model "learns" the unique response each individual has to each drug administered, making it superior to the empiric model found in other dosing calculators. Our products, the Intelligent Dosing System (IDS) and the Multi-Agent Intelligent Dosing System (MAIDS) individualize the dose of every drug, for every disease, in every patient to ensure that people enter the optimal or therapeutic window faster. Our company is dedicated to providing patients, prescribers, pharmaceutical manufacturers, payers, hospitals, VARS, and government agencies with a better way to dose pharmaceutical agents